Preview

Personalized Psychiatry and Neurology

Advanced search

Genetic aspects of primary headaches in Siberia (Russia)

https://doi.org/10.52667/2712-9179-2021-1-1-54-63

Full Text:

Abstract

Primary headaches are common neurological problem in the world. Migraine (M) and tension type headache (TTH) are the leaders in the structure of primary headaches in the population; (1) Background: The study of the association of single nucleotide variants (SNVs) of MTHFR (meth-ylenetetrahydrofolate reductase) and HTR2C (5-Hydroxytryptamine Receptor 2C) genes with M and TTH development in the European population in Siberia (Russia); (2) Methods: 192 adults were examined: 82 (42.7%) males and 110 (57.3%) females. Control group: 81 healthy adults, median age 49.5 [36; 59] years; 53 (66.7%) males and 27 (33.3%) females. Headache group consisted of 111 patients with primary headache, median age 54 [45; 64] years, including two subgroups: subgroup 1 (M) of 39 patients; subgroup 2 (TTH) of 72 patients. Carriage of alleles and genotypes rs1801133 and rs1801131 of the MTHFR gene and rs6318 of the HTR2C gene was determined using PCR-RT by TaqMan allelic discrimination technology; (3) Results: A statistically significant association of the carriage of the A allele rs1801133 of the MTHFR gene with the formation of M (p = 0.025) and TTH (p = 0.022), as well as the GA genotype with the development of TTH (p = 0.024) was revealed. Carriage of the G allele and the TG and GG genotypes of the MTHFR gene, associated with a decreased activity of the MTHFR enzyme, does not affect the development of primary headache. A statistically significant association was revealed between the carriage of the heterozygous GC genotype (rs6318) of the HTR2C gene and the formation of M (p = 0.013); (4) Conclusions: Carriage of the A allele (OR 1.77; 95% CI 1.09-2.89) and the GA genotype (OR 2.24; 95% CI 1.17-4.29) rs1801133 of the MTHFR gene is a risk factor for the development of TTH (p <0.05). Carriage of the A allele rs1801133 of the MTHFR gene is a risk factor for the development of M (OR 1.97; 95% CI 1.08-3.57; p <0.05). Carriage of the variant G allele and rs1801131 GT and GG genotypes associated with reduced activity of the MTHFR enzyme does not affect the development of primary headache. In the control group, the prevalence of the T allele associated with normal enzymatic activity was noted (p = 0.024). Carriage of the heterozygous genotype CG SNV rs6318 of the HTR2C gene increases the risk of developing migraine by 3.6 times.

About the Authors

A. V. Kondratiev
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Aleksey V. Kondratiev

660022, Krasnoyarsk



N. A. Shnayder
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University; V. M. Bekhterev National Medical Research Center for Neurology and Psychiatry
Russian Federation

Natalia A. Shnayder

192019, Saint-Petersburg; 660022, Krasnoyarsk; Tel.: +7-(812)-670-02-20



A. Shulmin
Vitebsk State Medical University
Belarus

Andrey V. Shulmin

210009, Vitebsk



D. V. Dmitrenko
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Diana V. Dmitrenko

660022, Krasnoyarsk; +7-(391)-201-65-24



V. V. Trefilova
V.M. Bekhterev National Medical Research Center for Neurology and Psychiatry; The Hospital for War Veterans
Russian Federation

Vera V. Trefilova

192019, Saint-Petersburg; 193079, St. Petersburg

 24*,



S. N. Zobova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Svetlana N. Zobova

660022, Krasnoyarsk



E. A. Kantimirova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Elena A. Kantimirova

660022, Krasnoyarsk



M. M. Petrova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Marina M. Petrova

660022, Krasnoyarsk



D. S. Kaskaeva
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation

Daria S. Kaskaeva

660022, Krasnoyarsk



E. E. Vaiman
V.M. Bekhterev National Medical Research Center for Neurology and Psychiatry
Russian Federation

Elena E. Vaiman

192019, Saint-Petersburg



R. F. Nasyrova
V.M. Bekhterev National Medical Research Center for Neurology and Psychiatry
Russian Federation

Regina F. Nasyrova

192019, Saint-Petersburg



References

1. Kondratev, A.V.; Shnayder, N.A.; Shulmin, A.V. Epidemiology of headaches. Modern problems of science and education 2015, 6. (in Russian)

2. Kondratev, A.V.; Shnayder, N.A.; Shulmin, A.V.; Lomakin A.I. Predictors of primary headaches. Problems of women health 2016, 1, 2-44 (in Russian).

3. Rainero, I.; Rubino, E.; Paemeleire, K.; Gai, A.; Vacca, A.; De Martino, P.; Gentile, S.; Sarchielli, P.; Pinessi, L. Genes and primary headaches: discovering new potential therapeutic targets. J. Headache Pain. 2013, 12, 14-61, doi:10.1186/1129-2377-14-61.

4. Li, X.; Zhou, X.; Peng, Y.; Liu, B.; Zhang, R.; Hu, J.; Yu, J.; Jia, C.; Sun, C. Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes. Biomed. Res. Int. 2014, 2014, 43-58, doi:10.1155/2014/435853.

5. Dux, M.; Santha, P.; Jancso, G. The role of chemosensitive afferent nerves and TRP ion channels in the pathomechanism of headaches. Pflugers Arch. 2012, 464, 239-248, doi: 10.1007/s00424-012-1142-7.

6. Rossi, C.; Pini, L.A.; Cupini, M.L.; Calabresi, P.; Sarchielli, P. Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels. Eur J Clin Pharmacol. 2008, 64, 1-8, doi: 10.1007/s00228-007-0391-4.

7. Tomaz de Magalhaes, M.; Nunez, S.C.; Kato, I.T.; Ribeiro, M.S. Light therapy modulates serotonin levels and blood flow in women with headache. A preliminary study. Experimental Biology and Medicine (Maywood, N.J.), 2015, 241, 40-45, doi: 10.1177/1535370215596383.

8. Vashadze, Sh.V.; Sardzhveladze, N.M. Relationship between serum blood serotonin and tension-type headache. Georgian Med News. 2009, 171, 44-47 (in Russian).

9. Antonaci, F.; Ghiotto, N.; Wu, S; Pucci, E.; Costa, A. Recent advances in migraine therapy. SpringerPlus 2016, 5, 637, doi:10.1186/s40064-016-2211-8.

10. Demarquay, G.; Lothe, A.; Royet, J.P.; Costes, N.; Mick, G.; Mauguiere, F.; Ryvlin, P. Brainstem changes in 5-HT1A receptor availability during migraine attack. Cephalalgia 2011, 31, 84-94, doi:10.1177/0333102410385581.

11. Yucel, Y.; Co§kun, S.; Cengiz, B.; et al. Association of Polymorphisms within the Serotonin Receptor Genes 5-HTR1A, 5-HTR1B, 5-HTR2A and 5-HTR2C and Migraine Susceptibility in a Turkish Population. Clin Psychopharmacol Neurosci. 2016, 14, 250-255, doi:10.9758/cpn.2016.14.3.250.

12. Oterino, A.; Castillo, J.; Pascual, J. et al. Genetic association study and meta-analysis of the HTR2C Cys23Ser polymorphism and migraine. J Headache Pain 2007, 8, 231-235, doi:10.1007/s10194-007-0399-2.

13. Tadtaeva, Z.G. Genetics of migraine (review). Bulletin of St. Petersburg State University. Series 11. Medicine. 2013, 1, 70-80 (in Russian).

14. Joutel, A.; Bousser, M.G.; Biousse, V.; La- bauge, P.; Chabriat, H.; Nibbio, A.; Maciazek, J.; Meyer, B.; Bach, M.A.; Weissenbach, J. A gene for familial hemiplegic migraine maps to chromosome 19. Nat. Genet. 1993, 5, 40-45.

15. Ophoff, R.A.; Terwindt, G.M.; Vergouwe, M.N.; van Eijk, R.; Mohrenweiser, H.; Litt, M.; Hofker, M.H.; Haan, J.; Ferrari, M.D.; Frants, R.R. A 3-Mb region for the familial hemiplegic migraine locus on 19p13.1-p13.2: exclusion of PRKCSH as a candidate gene. Dutch Migraine Genetic Research Group. Eur. J. Hum. Genet. 1996, 4, 321-328.

16. May, A.; Ophoff, R.A.; Terwindt, G.M.; Urban, C.; van Eijk, R.; Haan, J.; Diener, H.C.; Lindhout, D.; Frants, R.R.; Sandkuijl, L.A. Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet. 1995, 604-608.

17. Terwindt, G.M.; Ophoff, R.A.; van Eijk, R.; Vergouwe, M.N.; Haan, J.; Frants R.R.; Sandkuijl L.A.; Ferrari M.D.; Dutch Migraine Genetics Research Group. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology 2001, 56, 8, 1028-1032, doi:10.1212/wnl.56.8.1028.

18. Kors, E.E.; Vanmolkot, K.R.; Haan, J.; Frants, R.R.; van den Maagdenberg, A.M.; Ferrari, M.D. Recent findings in headache genetics. Curr Opin Neurol. 2004, 17, 3, 283-288, doi:10.1097/00019052-200406000-00008.

19. Russell, M.B.; Ducros, А. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011, 10, 457-470, doi: 10.1016/S1474-4422(11)70048-5.

20. Kopishinskaja, S.V.; Gustov, A.V. Genetic aspects of migraine. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2015, 115, 7, 124-129 (in Russian).

21. Ducros, A. Genetics of migraine. Rev. Neurol. (Paris). 2013, 169, 5, 360-371, doi: 10.1016/s1474-4422(02)00134-5.

22. Russell, M.B.; Levi, N.; Kaprio, J. Genetics of tension-type headache: a population based twin study. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2007, 144B, 982-986, doi: 10.1002/ajmg.b.30497.

23. Russell, M.B. Genetics of tension-type headache. J. Headache Pain. 2007, 8, 71-76, doi: 10.1007/s10194-007-0366-y.

24. Gaul, C.; Holle-Lee, D.; Straube, A. Botulinum toxin type A in headache treatment: Established and experimental indications. Nervenarzt. 2016, 87, 853-859, doi: 10.1007/s00115-016-0138-5.

25. Edgnulu, T.G.; Ozge, A.; Erdal, N.; Kuru, O.; Erdal, M.E. Association analysis of the functional MAOA gene promoter and MAOB gene intron 13 polymorphisms in tension type headache patients. Adv. Clin. Exp. Med. 2014, 23, 901-906, doi: 10.17219/acem/37333.

26. The International Classification of Headache Disorders 3rd edition, ichd-3. org.


For citation:


Kondratiev A.V., Shnayder N.A., Shulmin A., Dmitrenko D.V., Trefilova V.V., Zobova S.N., Kantimirova E.A., Petrova M.M., Kaskaeva D.S., Vaiman E.E., Nasyrova R.F. Genetic aspects of primary headaches in Siberia (Russia). Personalized Psychiatry and Neurology. 2021;1(1):54-63. https://doi.org/10.52667/2712-9179-2021-1-1-54-63

Views: 413


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2712-9179 (Online)